1,1'-Carbonyldiimidazole → HCID 178517619, 화합물

HRID 452113

반응식

HRID 452113 반응식
[NH:1]1[C:5]2[CH:6]=[CH:7][C:8]([NH2:10])=[CH:9][C:4]=2[N:3]=[CH:2]1.[CH:11]1([C:17]2[CH:24]=[CH:23][C:20]([CH:21]=O)=[CH:19][CH:18]=2)[CH2:16][CH2:15][CH2:14][CH2:13][CH2:12]1.[Si](C#N)(C)(C)C.[N:31]1([C:36](N2C=CN=C2)=[O:37])C=CN=[CH:32]1>[Pd]>[NH:1]1[C:5]2[CH:6]=[CH:7][C:8]([N:10]3[CH:21]([C:20]4[CH:23]=[CH:24][C:17]([CH:11]5[CH2:16][CH2:15][CH2:14][CH2:13][CH2:12]5)=[CH:18][CH:19]=4)[CH2:32][NH:31][C:36]3=[O:37])=[CH:9][C:4]=2[N:3]=[CH:2]1

참가 물질

6

반응물 4

HCID 682631,1'-CarbonyldiimidazoleHCID 82115Trimethylsilyl cyanideHCID 119689p-CyclohexylbenzaldehydeHCID 178507353HCID 178507353, 화합물

생성물 1

HCID 178517619HCID 178517619, 화합물

시약·촉매·용매 1

HCID 23938Palladium촉매

실험 절차

The compound was synthesized starting from 1H-benzo[d]imidazol-5-amine (0.400 g, 3 mmol), 4-cyclohexylbenzaldehyde (0.565 g, 3 mmol), TMSCN (0.375 mL, 3 mmol), Pd/C (10%, 0.02 g), TEA 1.05 mL, 7.5 mmol), di-(imidazol-1-yl)methanone (0.730 g, 4.5 mmol) as described in method 2.

후처리

  1. customThe compound was synthesized

출처 및 근거

ORD 기록
ord-e56637e6dea44464aadf04dd1a3636c7
출처 데이터셋
uspto-grants-2013_07
특허 번호
US08486940B2

연결된 노트

불러오는 중…